Carpal Tunnel/Amyloidosis Blood Sample Study

Completed

Conditions studied: Carpal Tunnel Syndrome, Amyloidosis

In brief

Carpal tunnel is an early manifestation of amyloidosis in a significant minority of patients. This specimen collection protocol will allow the investigators to screen patients with carpal tunnel syndrome for amyloidosis.

Key facts

Study ID

NCT02587728

Run by

University of Miami

People needed

10

Starts

2016-02-24

Expected to finish

2017-02-07

Last updated by the study team

2021-08-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1. Patients with diagnosed carpal tunnel syndrome based on Electromyography (EMG) results.
• 2. Patients with electrographic confirmation of median neuropathy at the wrist
• 3. Age ≥18 years
• 4. Ability to understand and willingness to sign a written informed consent document.

You may not qualify if…

• 1. Patients receiving hemodialysis
• 2. Known amyloidosis

Where it is running

• University of Miami — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.